

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.95835670 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.95835670 |
| 3 | postsynaptic membrane organization (GO:0001941) | 6.88599393 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64881688 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.64881688 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 6.11977509 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.04094386 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.94557008 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 5.92227626 |
| 10 | central nervous system myelination (GO:0022010) | 5.92227626 |
| 11 | complement activation, alternative pathway (GO:0006957) | 5.40472738 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 5.36634840 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 5.34789491 |
| 14 | presynaptic membrane assembly (GO:0097105) | 5.26658909 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.22791145 |
| 16 | eye photoreceptor cell differentiation (GO:0001754) | 5.18328231 |
| 17 | photoreceptor cell differentiation (GO:0046530) | 5.18328231 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.15887076 |
| 19 | urea metabolic process (GO:0019627) | 5.15364921 |
| 20 | urea cycle (GO:0000050) | 5.15364921 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.11931784 |
| 22 | kynurenine metabolic process (GO:0070189) | 5.09887550 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06825700 |
| 24 | indole-containing compound catabolic process (GO:0042436) | 5.05741610 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 5.05741610 |
| 26 | tryptophan catabolic process (GO:0006569) | 5.05741610 |
| 27 | protein carboxylation (GO:0018214) | 5.01872801 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.01872801 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.00674629 |
| 30 | dermatan sulfate biosynthetic process (GO:0030208) | 4.97275148 |
| 31 | cysteine metabolic process (GO:0006534) | 4.93524106 |
| 32 | regulation of complement activation (GO:0030449) | 4.83007679 |
| 33 | neuron cell-cell adhesion (GO:0007158) | 4.82522286 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.79941903 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.76054773 |
| 36 | tryptophan metabolic process (GO:0006568) | 4.76012646 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 4.73633397 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.71125840 |
| 39 | presynaptic membrane organization (GO:0097090) | 4.70006946 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.65782699 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.65782699 |
| 42 | astrocyte differentiation (GO:0048708) | 4.64666159 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.63521239 |
| 44 | bile acid metabolic process (GO:0008206) | 4.60966070 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.57732674 |
| 46 | dermatan sulfate metabolic process (GO:0030205) | 4.55563793 |
| 47 | locomotory exploration behavior (GO:0035641) | 4.42167239 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.41292527 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40304076 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.40304076 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.40304076 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.38591641 |
| 53 | lysine catabolic process (GO:0006554) | 4.33911421 |
| 54 | lysine metabolic process (GO:0006553) | 4.33911421 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 4.30503059 |
| 56 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.30194178 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.29303625 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.27900782 |
| 59 | aromatic amino acid family metabolic process (GO:0009072) | 4.26428441 |
| 60 | Sertoli cell development (GO:0060009) | 4.09669886 |
| 61 | phospholipid efflux (GO:0033700) | 4.08423510 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.06382293 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 4.06382293 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 4.05975830 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.01667584 |
| 66 | oligodendrocyte differentiation (GO:0048709) | 3.98083906 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.95912304 |
| 68 | glycine metabolic process (GO:0006544) | 3.95848295 |
| 69 | low-density lipoprotein particle clearance (GO:0034383) | 3.92146070 |
| 70 | ethanol oxidation (GO:0006069) | 3.90867437 |
| 71 | acetyl-CoA metabolic process (GO:0006084) | 3.89886580 |
| 72 | nephron tubule formation (GO:0072079) | 3.86921494 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 3.85283488 |
| 74 | chondroitin sulfate catabolic process (GO:0030207) | 3.82437857 |
| 75 | cholesterol efflux (GO:0033344) | 3.82430194 |
| 76 | regulation of plasminogen activation (GO:0010755) | 3.79781123 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.78732462 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.78685998 |
| 79 | valine metabolic process (GO:0006573) | 3.76239910 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.76014719 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.73492067 |
| 82 | glutamate metabolic process (GO:0006536) | 3.73282934 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 3.73138222 |
| 84 | neuronal stem cell maintenance (GO:0097150) | 3.71506109 |
| 85 | imidazole-containing compound metabolic process (GO:0052803) | 3.69079301 |
| 86 | bile acid and bile salt transport (GO:0015721) | 3.68914280 |
| 87 | fibrinolysis (GO:0042730) | 3.68170386 |
| 88 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.67592982 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.67177986 |
| 90 | fatty acid beta-oxidation (GO:0006635) | 3.66835959 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.65524843 |
| 92 | potassium ion import (GO:0010107) | 3.65296579 |
| 93 | enteric nervous system development (GO:0048484) | 3.64530118 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.62763989 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 3.62017085 |
| 96 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61596853 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.60812139 |
| 98 | organic acid catabolic process (GO:0016054) | 3.60812139 |
| 99 | arginine metabolic process (GO:0006525) | 3.59829977 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.59100424 |
| 101 | positive regulation of fatty acid oxidation (GO:0046321) | 3.58862070 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.58432580 |
| 103 | fatty acid oxidation (GO:0019395) | 3.58188602 |
| 104 | complement activation (GO:0006956) | 3.56399809 |
| 105 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.54577488 |
| 106 | cellular glucuronidation (GO:0052695) | 3.54080056 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 3.52748033 |
| 108 | sterol homeostasis (GO:0055092) | 3.52732958 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.52063302 |
| 110 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.52063302 |
| 111 | cellular potassium ion homeostasis (GO:0030007) | 3.51718968 |
| 112 | lipid oxidation (GO:0034440) | 3.51148921 |
| 113 | neutral lipid catabolic process (GO:0046461) | 3.49859532 |
| 114 | acylglycerol catabolic process (GO:0046464) | 3.49859532 |
| 115 | monocarboxylic acid catabolic process (GO:0072329) | 3.49711387 |
| 116 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.48293469 |
| 117 | fatty acid catabolic process (GO:0009062) | 3.47863638 |
| 118 | triglyceride catabolic process (GO:0019433) | 3.46481826 |
| 119 | complement activation, classical pathway (GO:0006958) | 3.45427210 |
| 120 | cytolysis (GO:0019835) | 3.44732482 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.44465516 |
| 122 | negative regulation of astrocyte differentiation (GO:0048712) | 3.42383414 |
| 123 | biotin metabolic process (GO:0006768) | 3.41987156 |
| 124 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 3.38620618 |
| 125 | developmental induction (GO:0031128) | 3.37690183 |
| 126 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.30984416 |
| 127 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.29511464 |
| 128 | cellular response to cholesterol (GO:0071397) | 3.29112978 |
| 129 | positive regulation of osteoblast proliferation (GO:0033690) | 3.24238889 |
| 130 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21769230 |
| 131 | exploration behavior (GO:0035640) | 3.21215313 |
| 132 | amino acid import (GO:0043090) | 3.20744660 |
| 133 | cGMP-mediated signaling (GO:0019934) | 3.20070884 |
| 134 | potassium ion homeostasis (GO:0055075) | 3.18642553 |
| 135 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.17811437 |
| 136 | axonal fasciculation (GO:0007413) | 3.16215283 |
| 137 | thalamus development (GO:0021794) | 3.16196308 |
| 138 | neuron recognition (GO:0008038) | 3.14860292 |
| 139 | regulation of respiratory system process (GO:0044065) | 3.14847515 |
| 140 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.13952227 |
| 141 | glial cell differentiation (GO:0010001) | 3.10475263 |
| 142 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.03877954 |
| 143 | L-amino acid import (GO:0043092) | 3.00534856 |
| 144 | auditory behavior (GO:0031223) | 2.94472370 |
| 145 | nucleobase catabolic process (GO:0046113) | 2.93288441 |
| 146 | positive regulation of vascular permeability (GO:0043117) | 2.92849846 |
| 147 | cranial nerve development (GO:0021545) | 2.92791958 |
| 148 | mechanosensory behavior (GO:0007638) | 2.91443726 |
| 149 | positive regulation of neurological system process (GO:0031646) | 2.90528082 |
| 150 | tongue development (GO:0043586) | 2.89818543 |
| 151 | sodium ion export (GO:0071436) | 2.85505069 |
| 152 | dendritic spine morphogenesis (GO:0060997) | 2.84701963 |
| 153 | neurotransmitter catabolic process (GO:0042135) | 2.83109070 |
| 154 | astrocyte development (GO:0014002) | 2.82800374 |
| 155 | neurotransmitter uptake (GO:0001504) | 2.82082514 |
| 156 | neuron fate commitment (GO:0048663) | 2.81776897 |
| 157 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.80015428 |
| 158 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.79080297 |
| 159 | response to auditory stimulus (GO:0010996) | 2.78108731 |
| 160 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.77215399 |
| 161 | negative regulation of glial cell differentiation (GO:0045686) | 2.72528803 |
| 162 | regulation of neurotransmitter uptake (GO:0051580) | 2.72229383 |
| 163 | neuron projection regeneration (GO:0031102) | 2.71416858 |
| 164 | nonmotile primary cilium assembly (GO:0035058) | 2.67718725 |
| 165 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.63846351 |
| 166 | cellular sodium ion homeostasis (GO:0006883) | 2.62243970 |
| 167 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.60605295 |
| 168 | C4-dicarboxylate transport (GO:0015740) | 2.60158934 |
| 169 | vocalization behavior (GO:0071625) | 2.59871935 |
| 170 | positive regulation of gliogenesis (GO:0014015) | 2.59818198 |
| 171 | auditory receptor cell differentiation (GO:0042491) | 2.59215088 |
| 172 | regulation of somitogenesis (GO:0014807) | 2.59083881 |
| 173 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.55841270 |
| 174 | cAMP-mediated signaling (GO:0019933) | 2.55459275 |
| 175 | * appendage development (GO:0048736) | 2.54009046 |
| 176 | * limb development (GO:0060173) | 2.54009046 |
| 177 | positive regulation of mesonephros development (GO:0061213) | 2.53602742 |
| 178 | spinal cord development (GO:0021510) | 2.53565660 |
| 179 | regulation of astrocyte differentiation (GO:0048710) | 2.50485970 |
| 180 | cellular response to sterol (GO:0036315) | 2.49555920 |
| 181 | synapse assembly (GO:0007416) | 2.49124229 |
| 182 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.48818682 |
| 183 | positive regulation of synapse assembly (GO:0051965) | 2.48100964 |
| 184 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.48034071 |
| 185 | notochord development (GO:0030903) | 2.46563740 |
| 186 | regulation of synapse structural plasticity (GO:0051823) | 2.45978975 |
| 187 | myelination (GO:0042552) | 2.45040662 |
| 188 | cell proliferation in forebrain (GO:0021846) | 2.43215111 |
| 189 | cyclic-nucleotide-mediated signaling (GO:0019935) | 2.43172648 |
| 190 | transmission of nerve impulse (GO:0019226) | 2.42998599 |
| 191 | positive regulation of neuroblast proliferation (GO:0002052) | 2.41329522 |
| 192 | regulation of gliogenesis (GO:0014013) | 2.39252038 |
| 193 | negative regulation of neuron differentiation (GO:0045665) | 2.38677573 |
| 194 | heart valve formation (GO:0003188) | 2.37077376 |
| 195 | paraxial mesoderm development (GO:0048339) | 2.36864764 |
| 196 | cerebellar Purkinje cell layer development (GO:0021680) | 2.35483575 |
| 197 | establishment of nucleus localization (GO:0040023) | 2.35409626 |
| 198 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.34752397 |
| 199 | axon ensheathment (GO:0008366) | 2.34600072 |
| 200 | ensheathment of neurons (GO:0007272) | 2.34600072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.72808795 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.04602471 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.61154188 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14306865 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.71542088 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.63399616 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.83436528 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.30837165 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93663602 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.27238025 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.11535054 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.99806141 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.97808509 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.86291321 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84805033 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.83803655 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76479219 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76479219 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.75379248 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.73464372 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66479687 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57247297 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53158392 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.51517161 |
| 25 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.45323538 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.44060221 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.42506823 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.39139791 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34866161 |
| 30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16441558 |
| 31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.15658348 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15142751 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13614788 |
| 34 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 2.05146796 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.02695711 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01688879 |
| 37 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7999526 |
| 38 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99311382 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99228141 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.96594507 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89388486 |
| 42 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.72874654 |
| 43 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.69233277 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.69069475 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64107852 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.63093099 |
| 47 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62986865 |
| 48 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.61510237 |
| 49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58120348 |
| 50 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57771110 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56170557 |
| 52 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.52749199 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.51285498 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38369704 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38236871 |
| 56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36586104 |
| 57 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31172782 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29159241 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25651957 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24529164 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18307958 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17418380 |
| 63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15941998 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15521723 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15416372 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15143433 |
| 67 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14837561 |
| 68 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14694360 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13536864 |
| 70 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12431329 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12347819 |
| 72 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11989653 |
| 73 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11519220 |
| 74 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.11364471 |
| 75 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.11206529 |
| 76 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07521691 |
| 77 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05957626 |
| 78 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.03854567 |
| 79 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.03712507 |
| 80 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03172732 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02189656 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01373719 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01198684 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00502616 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98779455 |
| 86 | * SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.97653226 |
| 87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95937023 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95719256 |
| 89 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95457490 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94936212 |
| 91 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93544281 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92287350 |
| 93 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.92112595 |
| 94 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91876143 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91592679 |
| 96 | * AR_19668381_ChIP-Seq_PC3_Human | 0.91431610 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90491467 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89266500 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89165202 |
| 100 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.89129829 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89053333 |
| 102 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88936349 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88878447 |
| 104 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88563283 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88097411 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87701118 |
| 107 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87648477 |
| 108 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87487145 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87274821 |
| 110 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86979941 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85893936 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85706915 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85340965 |
| 114 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.85326975 |
| 115 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.84295393 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81473078 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81200862 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81143596 |
| 119 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80850597 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80697234 |
| 121 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80550855 |
| 122 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79105836 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.78989017 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78255159 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.78128889 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78097356 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77934066 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77268946 |
| 129 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77033613 |
| 130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76625950 |
| 131 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76025507 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76015240 |
| 133 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.75966125 |
| 134 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75604516 |
| 135 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.75480501 |
| 136 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74861616 |
| 137 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.74724298 |
| 138 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74492680 |
| 139 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74472436 |
| 140 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72146187 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70184695 |
| 142 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69917457 |
| 143 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.68522798 |
| 144 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65024873 |
| 145 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65024873 |
| 146 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63833724 |
| 147 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63056145 |
| 148 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62942265 |
| 149 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61947456 |
| 150 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61129498 |
| 151 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.60532765 |
| 152 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60223320 |
| 153 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.59421636 |
| 154 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.55924001 |
| 155 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.55924001 |
| 156 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.54865390 |
| 157 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.54500700 |
| 158 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.54241024 |
| 159 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53946979 |
| 160 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53573940 |
| 161 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52822399 |
| 162 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.52474121 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51848049 |
| 164 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51489250 |
| 165 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51241122 |
| 166 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.51129529 |
| 167 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50626582 |
| 168 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50111635 |
| 169 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49327998 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.49248908 |
| 171 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48138502 |
| 172 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47922655 |
| 173 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47770424 |
| 174 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47088340 |
| 175 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.46039699 |
| 176 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.45812856 |
| 177 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.45646175 |
| 178 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45611999 |
| 179 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.45068835 |
| 180 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.44400289 |
| 181 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44167173 |
| 182 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44016057 |
| 183 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43755475 |
| 184 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43462791 |
| 185 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.43410341 |
| 186 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.43035521 |
| 187 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.42631451 |
| 188 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.42199849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.62486007 |
| 2 | MP0005360_urolithiasis | 6.79424860 |
| 3 | MP0005365_abnormal_bile_salt | 5.86083708 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.66402019 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.43021442 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.97224188 |
| 7 | MP0003136_yellow_coat_color | 3.73191131 |
| 8 | MP0003252_abnormal_bile_duct | 3.57062516 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.50286465 |
| 10 | MP0002653_abnormal_ependyma_morphology | 3.27138066 |
| 11 | MP0004885_abnormal_endolymph | 3.00838270 |
| 12 | MP0009840_abnormal_foam_cell | 2.96123203 |
| 13 | MP0005083_abnormal_biliary_tract | 2.78313039 |
| 14 | MP0003122_maternal_imprinting | 2.68746987 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.61357264 |
| 16 | MP0005670_abnormal_white_adipose | 2.60462945 |
| 17 | MP0000579_abnormal_nail_morphology | 2.60308021 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.57886263 |
| 19 | MP0000778_abnormal_nervous_system | 2.57220742 |
| 20 | MP0005332_abnormal_amino_acid | 2.53418512 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.41071625 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.36179900 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.33608972 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.31115485 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 2.31005042 |
| 26 | MP0003880_abnormal_central_pattern | 2.24485531 |
| 27 | MP0003195_calcinosis | 2.24113706 |
| 28 | MP0000609_abnormal_liver_physiology | 2.19528560 |
| 29 | MP0001502_abnormal_circadian_rhythm | 2.13816799 |
| 30 | MP0000566_synostosis | 2.13710431 |
| 31 | MP0005646_abnormal_pituitary_gland | 2.10077889 |
| 32 | MP0009379_abnormal_foot_pigmentation | 2.01822294 |
| 33 | MP0001984_abnormal_olfaction | 2.00504713 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.89673239 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.85809125 |
| 36 | MP0003635_abnormal_synaptic_transmissio | 1.81127664 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.75283482 |
| 38 | MP0002736_abnormal_nociception_after | 1.74708406 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.74312470 |
| 40 | MP0001486_abnormal_startle_reflex | 1.72763934 |
| 41 | MP0005171_absent_coat_pigmentation | 1.71795048 |
| 42 | MP0002064_seizures | 1.69330788 |
| 43 | MP0002938_white_spotting | 1.69062040 |
| 44 | MP0004130_abnormal_muscle_cell | 1.68722651 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.67884708 |
| 46 | MP0000955_abnormal_spinal_cord | 1.64775887 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.61330480 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.56625441 |
| 49 | MP0003868_abnormal_feces_composition | 1.53776550 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.53460933 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.52954086 |
| 52 | MP0000026_abnormal_inner_ear | 1.52501151 |
| 53 | MP0002272_abnormal_nervous_system | 1.50533893 |
| 54 | MP0004142_abnormal_muscle_tone | 1.50309089 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.50078133 |
| 56 | MP0008789_abnormal_olfactory_epithelium | 1.47632983 |
| 57 | MP0003634_abnormal_glial_cell | 1.47190862 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46729691 |
| 59 | MP0004270_analgesia | 1.46433294 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.43706855 |
| 61 | MP0003011_delayed_dark_adaptation | 1.40977277 |
| 62 | MP0002572_abnormal_emotion/affect_behav | 1.39947015 |
| 63 | MP0001293_anophthalmia | 1.38188569 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.36494920 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.35712052 |
| 66 | MP0005499_abnormal_olfactory_system | 1.35712052 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.35651295 |
| 68 | MP0002254_reproductive_system_inflammat | 1.35479262 |
| 69 | MP0000049_abnormal_middle_ear | 1.35149840 |
| 70 | MP0001764_abnormal_homeostasis | 1.33211003 |
| 71 | MP0002233_abnormal_nose_morphology | 1.31735145 |
| 72 | MP0002697_abnormal_eye_size | 1.31616599 |
| 73 | MP0002971_abnormal_brown_adipose | 1.31420769 |
| 74 | MP0009745_abnormal_behavioral_response | 1.31325847 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.29358980 |
| 76 | MP0002152_abnormal_brain_morphology | 1.28970139 |
| 77 | MP0000762_abnormal_tongue_morphology | 1.27932890 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.26091043 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.25949584 |
| 80 | MP0002638_abnormal_pupillary_reflex | 1.25104130 |
| 81 | MP0003186_abnormal_redox_activity | 1.24670270 |
| 82 | MP0004133_heterotaxia | 1.24289791 |
| 83 | MP0005647_abnormal_sex_gland | 1.24063367 |
| 84 | MP0003632_abnormal_nervous_system | 1.20643644 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.19969167 |
| 86 | MP0003938_abnormal_ear_development | 1.18965932 |
| 87 | MP0002882_abnormal_neuron_morphology | 1.18543282 |
| 88 | MP0001661_extended_life_span | 1.17404124 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 1.17371962 |
| 90 | MP0003861_abnormal_nervous_system | 1.17175109 |
| 91 | MP0005275_abnormal_skin_tensile | 1.17004544 |
| 92 | MP0003123_paternal_imprinting | 1.16944755 |
| 93 | MP0005334_abnormal_fat_pad | 1.14247630 |
| 94 | MP0000598_abnormal_liver_morphology | 1.13891894 |
| 95 | MP0002234_abnormal_pharynx_morphology | 1.13852791 |
| 96 | MP0000920_abnormal_myelination | 1.12335264 |
| 97 | MP0005375_adipose_tissue_phenotype | 1.11234972 |
| 98 | MP0002876_abnormal_thyroid_physiology | 1.10991905 |
| 99 | MP0001529_abnormal_vocalization | 1.10438023 |
| 100 | MP0009643_abnormal_urine_homeostasis | 1.09926754 |
| 101 | MP0002733_abnormal_thermal_nociception | 1.07383032 |
| 102 | MP0010368_abnormal_lymphatic_system | 1.02051190 |
| 103 | MP0002067_abnormal_sensory_capabilities | 1.01983783 |
| 104 | MP0003283_abnormal_digestive_organ | 1.00191053 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.99764689 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.99490082 |
| 107 | MP0003121_genomic_imprinting | 0.99200438 |
| 108 | MP0003690_abnormal_glial_cell | 0.98986410 |
| 109 | MP0009053_abnormal_anal_canal | 0.98892466 |
| 110 | MP0005391_vision/eye_phenotype | 0.98627498 |
| 111 | MP0003879_abnormal_hair_cell | 0.97474691 |
| 112 | MP0009697_abnormal_copulation | 0.96353918 |
| 113 | MP0001970_abnormal_pain_threshold | 0.96052209 |
| 114 | MP0002116_abnormal_craniofacial_bone | 0.95998548 |
| 115 | MP0005253_abnormal_eye_physiology | 0.95530867 |
| 116 | MP0002092_abnormal_eye_morphology | 0.95053949 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.93364108 |
| 118 | MP0005195_abnormal_posterior_eye | 0.93186139 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.93107843 |
| 120 | MP0003119_abnormal_digestive_system | 0.93102275 |
| 121 | MP0009115_abnormal_fat_cell | 0.93093191 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.92943005 |
| 123 | MP0000604_amyloidosis | 0.92275063 |
| 124 | MP0002735_abnormal_chemical_nociception | 0.92179724 |
| 125 | MP0003755_abnormal_palate_morphology | 0.92058531 |
| 126 | MP0002184_abnormal_innervation | 0.92052967 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.91973198 |
| 128 | MP0000428_abnormal_craniofacial_morphol | 0.91893014 |
| 129 | MP0001905_abnormal_dopamine_level | 0.90441592 |
| 130 | MP0003633_abnormal_nervous_system | 0.90432845 |
| 131 | MP0009763_increased_sensitivity_to | 0.90236213 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.87781379 |
| 133 | MP0003942_abnormal_urinary_system | 0.87242702 |
| 134 | MP0003787_abnormal_imprinting | 0.85788096 |
| 135 | MP0005448_abnormal_energy_balance | 0.83538269 |
| 136 | MP0001286_abnormal_eye_development | 0.83114423 |
| 137 | MP0003631_nervous_system_phenotype | 0.82323570 |
| 138 | MP0002970_abnormal_white_adipose | 0.81714112 |
| 139 | MP0005220_abnormal_exocrine_pancreas | 0.81080088 |
| 140 | MP0008569_lethality_at_weaning | 0.80929686 |
| 141 | MP0002066_abnormal_motor_capabilities/c | 0.79917781 |
| 142 | MP0006276_abnormal_autonomic_nervous | 0.79668973 |
| 143 | MP0003656_abnormal_erythrocyte_physiolo | 0.78840682 |
| 144 | MP0005535_abnormal_body_temperature | 0.78422562 |
| 145 | MP0005451_abnormal_body_composition | 0.76192929 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.75326679 |
| 147 | MP0000639_abnormal_adrenal_gland | 0.73865664 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.72358519 |
| 149 | MP0002089_abnormal_postnatal_growth/wei | 0.71079861 |
| 150 | MP0005377_hearing/vestibular/ear_phenot | 0.70851645 |
| 151 | MP0004272_abnormal_basement_membrane | 0.69136783 |
| 152 | MP0003959_abnormal_lean_body | 0.67449319 |
| 153 | MP0009384_cardiac_valve_regurgitation | 0.66518127 |
| 154 | MP0009672_abnormal_birth_weight | 0.65974477 |
| 155 | MP0001756_abnormal_urination | 0.65800767 |
| 156 | MP0009764_decreased_sensitivity_to | 0.65714689 |
| 157 | MP0006036_abnormal_mitochondrial_physio | 0.64886047 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.64793374 |
| 159 | MP0002060_abnormal_skin_morphology | 0.63454534 |
| 160 | MP0000003_abnormal_adipose_tissue | 0.61815625 |
| 161 | MP0001881_abnormal_mammary_gland | 0.60460669 |
| 162 | MP0005636_abnormal_mineral_homeostasis | 0.59725326 |
| 163 | MP0003329_amyloid_beta_deposits | 0.59667826 |
| 164 | MP0009765_abnormal_xenobiotic_induced | 0.55005201 |
| 165 | MP0002168_other_aberrant_phenotype | 0.54635279 |
| 166 | MP0004883_abnormal_blood_vessel | 0.54227561 |
| 167 | MP0005266_abnormal_metabolism | 0.53691333 |
| 168 | MP0008469_abnormal_protein_level | 0.53218727 |
| 169 | MP0005164_abnormal_response_to | 0.52793274 |
| 170 | MP0003953_abnormal_hormone_level | 0.52406350 |
| 171 | MP0002249_abnormal_larynx_morphology | 0.52249884 |
| 172 | MP0005084_abnormal_gallbladder_morpholo | 0.52196915 |
| 173 | MP0002295_abnormal_pulmonary_circulatio | 0.50274487 |
| 174 | MP0000013_abnormal_adipose_tissue | 0.49418047 |
| 175 | MP0005408_hypopigmentation | 0.48848918 |
| 176 | MP0002282_abnormal_trachea_morphology | 0.47559974 |
| 177 | MP0002796_impaired_skin_barrier | 0.44559013 |
| 178 | MP0005395_other_phenotype | 0.44380387 |
| 179 | MP0005452_abnormal_adipose_tissue | 0.44049528 |
| 180 | MP0005503_abnormal_tendon_morphology | 0.43418089 |
| 181 | MP0002108_abnormal_muscle_morphology | 0.42199791 |
| 182 | MP0000249_abnormal_blood_vessel | 0.41219152 |
| 183 | MP0002090_abnormal_vision | 0.39177175 |
| 184 | MP0004858_abnormal_nervous_system | 0.37123777 |
| 185 | MP0005595_abnormal_vascular_smooth | 0.36720279 |
| 186 | MP0001243_abnormal_dermal_layer | 0.36687018 |
| 187 | MP0000230_abnormal_systemic_arterial | 0.36641568 |
| 188 | MP0002269_muscular_atrophy | 0.36383592 |
| 189 | MP0002928_abnormal_bile_duct | 0.34653091 |
| 190 | MP0002136_abnormal_kidney_physiology | 0.34592402 |
| 191 | MP0005023_abnormal_wound_healing | 0.33669122 |
| 192 | MP0003638_abnormal_response/metabolism_ | 0.32632695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.38620269 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.69254494 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.44944806 |
| 4 | Xanthomatosis (HP:0000991) | 6.05968873 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.03643992 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.74182555 |
| 7 | Complement deficiency (HP:0004431) | 5.70064970 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.52284513 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.51195669 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.70649129 |
| 11 | Hyperammonemia (HP:0001987) | 4.54484132 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 4.49792400 |
| 13 | Hyperglycinemia (HP:0002154) | 4.49276485 |
| 14 | Epidermoid cyst (HP:0200040) | 4.47954031 |
| 15 | Hyperglycinuria (HP:0003108) | 4.42700441 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36742085 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.33520209 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33520209 |
| 19 | Ketosis (HP:0001946) | 4.28132307 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15538027 |
| 21 | Abnormality of complement system (HP:0005339) | 4.08597783 |
| 22 | Joint hemorrhage (HP:0005261) | 3.98719234 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.96283078 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.95675597 |
| 25 | Abnormality of the diencephalon (HP:0010662) | 3.80332569 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.79106507 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.63070462 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.62043460 |
| 29 | Fat malabsorption (HP:0002630) | 3.52929933 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.52449210 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.50888939 |
| 32 | Rib fusion (HP:0000902) | 3.50470579 |
| 33 | Morphological abnormality of the inner ear (HP:0011390) | 3.46889764 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41379668 |
| 35 | Septo-optic dysplasia (HP:0100842) | 3.37410329 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31772764 |
| 37 | Abnormality of cochlea (HP:0000375) | 3.21874060 |
| 38 | Myocardial infarction (HP:0001658) | 3.16853197 |
| 39 | Ketoacidosis (HP:0001993) | 3.12555675 |
| 40 | Abnormality of the ischium (HP:0003174) | 3.10234117 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.04890812 |
| 42 | Skin nodule (HP:0200036) | 3.02913198 |
| 43 | Spastic diplegia (HP:0001264) | 2.94594569 |
| 44 | Spontaneous abortion (HP:0005268) | 2.88375453 |
| 45 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.86593159 |
| 46 | Absent epiphyses (HP:0010577) | 2.86593159 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.84907800 |
| 48 | Missing ribs (HP:0000921) | 2.82427936 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80725404 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.79267896 |
| 51 | Hyperbilirubinemia (HP:0002904) | 2.78622524 |
| 52 | Esophageal atresia (HP:0002032) | 2.78349754 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.77900407 |
| 54 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.73730634 |
| 55 | Increased circulating renin level (HP:0000848) | 2.68792204 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66765326 |
| 57 | Urethral obstruction (HP:0000796) | 2.65311191 |
| 58 | Steatorrhea (HP:0002570) | 2.62199583 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.59815180 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.56251217 |
| 61 | Vertebral clefting (HP:0008428) | 2.54870050 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.53824960 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.52796156 |
| 64 | Split foot (HP:0001839) | 2.52085393 |
| 65 | Hemiparesis (HP:0001269) | 2.51836279 |
| 66 | Abnormal cartilage morphology (HP:0002763) | 2.49628621 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.48497807 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.47702582 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.45925877 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.45925877 |
| 71 | Hypertriglyceridemia (HP:0002155) | 2.45657433 |
| 72 | Gastrointestinal atresia (HP:0002589) | 2.45538639 |
| 73 | Mitral stenosis (HP:0001718) | 2.45408755 |
| 74 | Renal duplication (HP:0000075) | 2.43922575 |
| 75 | Amyloidosis (HP:0011034) | 2.42885844 |
| 76 | Metabolic acidosis (HP:0001942) | 2.40680971 |
| 77 | Neurofibrillary tangles (HP:0002185) | 2.39216571 |
| 78 | Arthropathy (HP:0003040) | 2.37548358 |
| 79 | Megalencephaly (HP:0001355) | 2.35452879 |
| 80 | Hemivertebrae (HP:0002937) | 2.30644593 |
| 81 | Hydroxyprolinuria (HP:0003080) | 2.29738171 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 2.29738171 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.29670463 |
| 84 | Action tremor (HP:0002345) | 2.29582174 |
| 85 | Lethargy (HP:0001254) | 2.27887879 |
| 86 | Esophageal varix (HP:0002040) | 2.27372500 |
| 87 | Neonatal onset (HP:0003623) | 2.26829671 |
| 88 | Cholelithiasis (HP:0001081) | 2.25454798 |
| 89 | Cholecystitis (HP:0001082) | 2.24817446 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.24817446 |
| 91 | Hypoplasia of the ulna (HP:0003022) | 2.23965931 |
| 92 | Supernumerary ribs (HP:0005815) | 2.23598050 |
| 93 | Back pain (HP:0003418) | 2.23552230 |
| 94 | Anomalous pulmonary venous return (HP:0010772) | 2.22597239 |
| 95 | Turricephaly (HP:0000262) | 2.22415671 |
| 96 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.20064317 |
| 97 | Vascular calcification (HP:0004934) | 2.17159927 |
| 98 | Cutaneous finger syndactyly (HP:0010554) | 2.14508019 |
| 99 | Partial duplication of thumb phalanx (HP:0009944) | 2.10973228 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.10968801 |
| 101 | Irritability (HP:0000737) | 2.10332183 |
| 102 | Elfin facies (HP:0004428) | 2.09849480 |
| 103 | Abnormality of the aortic arch (HP:0012303) | 2.08854889 |
| 104 | Malnutrition (HP:0004395) | 2.08585487 |
| 105 | Pancreatitis (HP:0001733) | 2.08527959 |
| 106 | Brushfield spots (HP:0001088) | 2.07880828 |
| 107 | Intestinal atresia (HP:0011100) | 2.07687928 |
| 108 | Myokymia (HP:0002411) | 2.07181376 |
| 109 | Gout (HP:0001997) | 2.07108428 |
| 110 | Glomerulonephritis (HP:0000099) | 2.05411036 |
| 111 | Short 4th metacarpal (HP:0010044) | 2.04881873 |
| 112 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.04881873 |
| 113 | Oligomenorrhea (HP:0000876) | 2.04761832 |
| 114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03071686 |
| 115 | Cutaneous syndactyly (HP:0012725) | 2.02745597 |
| 116 | Overriding aorta (HP:0002623) | 2.02175169 |
| 117 | Peripheral hypomyelination (HP:0007182) | 2.01585792 |
| 118 | Double outlet right ventricle (HP:0001719) | 2.01311569 |
| 119 | Congenital malformation of the right heart (HP:0011723) | 2.01311569 |
| 120 | Maternal diabetes (HP:0009800) | 2.00971121 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 2.00282048 |
| 122 | Hyperglycemia (HP:0003074) | 2.00143237 |
| 123 | Late onset (HP:0003584) | 2.00082880 |
| 124 | 11 pairs of ribs (HP:0000878) | 1.99690474 |
| 125 | Enlarged kidneys (HP:0000105) | 1.98122905 |
| 126 | Renovascular hypertension (HP:0100817) | 1.96992182 |
| 127 | Pseudobulbar signs (HP:0002200) | 1.96496419 |
| 128 | Abnormal eating behavior (HP:0100738) | 1.96380263 |
| 129 | Vitreoretinal degeneration (HP:0000655) | 1.96077671 |
| 130 | * Anophthalmia (HP:0000528) | 1.94391219 |
| 131 | Renal dysplasia (HP:0000110) | 1.92824323 |
| 132 | Acanthosis nigricans (HP:0000956) | 1.92720046 |
| 133 | True hermaphroditism (HP:0010459) | 1.92044364 |
| 134 | Acanthocytosis (HP:0001927) | 1.91711782 |
| 135 | Cerebellar dysplasia (HP:0007033) | 1.90422366 |
| 136 | Focal motor seizures (HP:0011153) | 1.87997617 |
| 137 | Vomiting (HP:0002013) | 1.87174561 |
| 138 | Cerebral edema (HP:0002181) | 1.86252638 |
| 139 | Hyperacusis (HP:0010780) | 1.85767006 |
| 140 | Abnormality of the pulmonary veins (HP:0011718) | 1.85220301 |
| 141 | Abnormality of the gallbladder (HP:0005264) | 1.84818813 |
| 142 | Preaxial foot polydactyly (HP:0001841) | 1.84141666 |
| 143 | Optic nerve hypoplasia (HP:0000609) | 1.83927634 |
| 144 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.83706707 |
| 145 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.83542645 |
| 146 | Abnormality of the nasal septum (HP:0000419) | 1.82604518 |
| 147 | Metabolic alkalosis (HP:0200114) | 1.82534493 |
| 148 | Sclerocornea (HP:0000647) | 1.79985532 |
| 149 | Broad thumb (HP:0011304) | 1.79689776 |
| 150 | Hepatoblastoma (HP:0002884) | 1.79039165 |
| 151 | Opisthotonus (HP:0002179) | 1.77674287 |
| 152 | Insomnia (HP:0100785) | 1.77287452 |
| 153 | Gingival bleeding (HP:0000225) | 1.75097986 |
| 154 | Nephritis (HP:0000123) | 1.74695228 |
| 155 | Abnormality of the intervertebral disk (HP:0005108) | 1.74456531 |
| 156 | Abnormality of the Achilles tendon (HP:0005109) | 1.74172031 |
| 157 | Nephronophthisis (HP:0000090) | 1.73766063 |
| 158 | Polydipsia (HP:0001959) | 1.73313698 |
| 159 | Abnormal drinking behavior (HP:0030082) | 1.73313698 |
| 160 | * Synostosis of carpal bones (HP:0005048) | 1.71941671 |
| 161 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.71932935 |
| 162 | Thrombophlebitis (HP:0004418) | 1.71179573 |
| 163 | Truncus arteriosus (HP:0001660) | 1.70082809 |
| 164 | Stroke (HP:0001297) | 1.68950493 |
| 165 | Myoglobinuria (HP:0002913) | 1.68924751 |
| 166 | Partial duplication of the phalanx of hand (HP:0009999) | 1.68697308 |
| 167 | * Abnormality of the 4th metacarpal (HP:0010012) | 1.68484776 |
| 168 | Type II lissencephaly (HP:0007260) | 1.68473807 |
| 169 | Pigmentary retinal degeneration (HP:0001146) | 1.68436757 |
| 170 | Bronchomalacia (HP:0002780) | 1.68331067 |
| 171 | Menorrhagia (HP:0000132) | 1.68299241 |
| 172 | Laryngomalacia (HP:0001601) | 1.68092856 |
| 173 | Peritonitis (HP:0002586) | 1.66843666 |
| 174 | Diplopia (HP:0000651) | 1.66104951 |
| 175 | Abnormality of binocular vision (HP:0011514) | 1.66104951 |
| 176 | Tracheomalacia (HP:0002779) | 1.66041507 |
| 177 | Aplasia of the phalanges of the hand (HP:0009802) | 1.63165331 |
| 178 | Aplasia involving bones of the extremities (HP:0009825) | 1.63165331 |
| 179 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.63165331 |
| 180 | Rickets (HP:0002748) | 1.61843537 |
| 181 | Bowel incontinence (HP:0002607) | 1.61550828 |
| 182 | Supernumerary spleens (HP:0009799) | 1.60521482 |
| 183 | Ectopia lentis (HP:0001083) | 1.60318637 |
| 184 | Abnormal sex determination (HP:0012244) | 1.58463610 |
| 185 | Sex reversal (HP:0012245) | 1.58463610 |
| 186 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.57716850 |
| 187 | Vertebral hypoplasia (HP:0008417) | 1.57716850 |
| 188 | Polyphagia (HP:0002591) | 1.57502742 |
| 189 | Sleep apnea (HP:0010535) | 1.57093068 |
| 190 | Milia (HP:0001056) | 1.55628736 |
| 191 | Broad phalanges of the hand (HP:0009768) | 1.54096079 |
| 192 | Limb dystonia (HP:0002451) | 1.53843162 |
| 193 | Absent septum pellucidum (HP:0001331) | 1.52651103 |
| 194 | Abnormality of the vitreous humor (HP:0004327) | 1.51548988 |
| 195 | Broad finger (HP:0001500) | 1.51297671 |
| 196 | Dysdiadochokinesis (HP:0002075) | 1.51212666 |
| 197 | Glossoptosis (HP:0000162) | 1.50789869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.79078035 |
| 2 | SIK1 | 5.06057759 |
| 3 | NTRK2 | 4.15275256 |
| 4 | TRIB3 | 4.14582318 |
| 5 | ERN1 | 4.11485579 |
| 6 | NTRK3 | 3.87632458 |
| 7 | MARK1 | 3.72459696 |
| 8 | FGFR4 | 3.58728240 |
| 9 | CASK | 3.16450047 |
| 10 | EPHA4 | 3.05584690 |
| 11 | MAPK15 | 2.67171736 |
| 12 | CAMK1D | 2.65239643 |
| 13 | PKN2 | 2.61923334 |
| 14 | LATS1 | 2.52418346 |
| 15 | PNCK | 2.48375322 |
| 16 | ERBB4 | 2.24829913 |
| 17 | PRKD3 | 2.15559085 |
| 18 | INSRR | 1.98493115 |
| 19 | CAMK1G | 1.86842903 |
| 20 | RIPK1 | 1.83557191 |
| 21 | PDGFRA | 1.75263049 |
| 22 | MST1R | 1.74419537 |
| 23 | FGFR2 | 1.70712877 |
| 24 | UHMK1 | 1.69339776 |
| 25 | PTK6 | 1.65307395 |
| 26 | EPHA3 | 1.44761978 |
| 27 | MAP2K4 | 1.44292007 |
| 28 | ICK | 1.43488758 |
| 29 | NEK6 | 1.40855073 |
| 30 | MKNK1 | 1.40549382 |
| 31 | DYRK2 | 1.36559963 |
| 32 | MAPKAPK5 | 1.35926204 |
| 33 | MAPK11 | 1.34620787 |
| 34 | MET | 1.34548368 |
| 35 | DDR2 | 1.30731726 |
| 36 | PKN1 | 1.28734289 |
| 37 | FLT3 | 1.25418603 |
| 38 | PRKAA2 | 1.22302047 |
| 39 | CDK6 | 1.21982502 |
| 40 | LATS2 | 1.20432038 |
| 41 | SGK494 | 1.17264562 |
| 42 | SGK223 | 1.17264562 |
| 43 | WNK4 | 1.13944592 |
| 44 | EPHB2 | 1.13264507 |
| 45 | MAP3K10 | 1.11945042 |
| 46 | ERBB2 | 1.11304324 |
| 47 | EPHB1 | 1.10544250 |
| 48 | PDK3 | 1.07825471 |
| 49 | PDK4 | 1.07825471 |
| 50 | NEK9 | 1.06661665 |
| 51 | PRKCG | 1.06641187 |
| 52 | MAPK13 | 1.04336609 |
| 53 | PIK3CG | 1.03498767 |
| 54 | CAMK2D | 1.03395430 |
| 55 | CDK3 | 1.02870756 |
| 56 | MTOR | 1.00547319 |
| 57 | CAMK2B | 1.00345322 |
| 58 | TAOK3 | 0.98593922 |
| 59 | TYRO3 | 0.97836580 |
| 60 | JAK2 | 0.94270825 |
| 61 | MAP3K4 | 0.93636548 |
| 62 | DAPK2 | 0.91990675 |
| 63 | MAP3K7 | 0.89229580 |
| 64 | GSK3A | 0.88412389 |
| 65 | TNK2 | 0.86631041 |
| 66 | BMX | 0.86588318 |
| 67 | STK38L | 0.86391255 |
| 68 | MKNK2 | 0.86355434 |
| 69 | DYRK1B | 0.86034936 |
| 70 | SGK2 | 0.84739393 |
| 71 | FER | 0.84697675 |
| 72 | FGFR3 | 0.84523568 |
| 73 | PTK2 | 0.82858467 |
| 74 | LMTK2 | 0.80457361 |
| 75 | RET | 0.78735653 |
| 76 | MAP2K2 | 0.78585862 |
| 77 | SGK1 | 0.77898835 |
| 78 | ABL2 | 0.77817501 |
| 79 | FGFR1 | 0.77100063 |
| 80 | FRK | 0.75828008 |
| 81 | PRKAA1 | 0.74916268 |
| 82 | ROCK2 | 0.71977620 |
| 83 | PRKCZ | 0.71111327 |
| 84 | STK11 | 0.70709211 |
| 85 | PAK2 | 0.69661376 |
| 86 | MARK2 | 0.69466227 |
| 87 | WNK3 | 0.69190549 |
| 88 | MAP2K1 | 0.67583647 |
| 89 | PAK3 | 0.67099766 |
| 90 | CAMK2A | 0.66375642 |
| 91 | MAP2K7 | 0.65455376 |
| 92 | TTN | 0.65288925 |
| 93 | DYRK1A | 0.65114863 |
| 94 | PRKACG | 0.64998036 |
| 95 | CDK5 | 0.64985003 |
| 96 | PAK6 | 0.62698917 |
| 97 | CAMK1 | 0.61040419 |
| 98 | TGFBR2 | 0.61032970 |
| 99 | CAMKK1 | 0.60951212 |
| 100 | PLK2 | 0.59487235 |
| 101 | MAPK10 | 0.58510636 |
| 102 | CDK4 | 0.58425651 |
| 103 | RPS6KB1 | 0.58342081 |
| 104 | CSNK1G1 | 0.57418272 |
| 105 | CDK12 | 0.57314217 |
| 106 | PDGFRB | 0.57000543 |
| 107 | CSK | 0.56432085 |
| 108 | ROCK1 | 0.56386044 |
| 109 | JAK1 | 0.55850650 |
| 110 | EEF2K | 0.54977529 |
| 111 | NTRK1 | 0.54502113 |
| 112 | STK39 | 0.53161635 |
| 113 | FES | 0.52965300 |
| 114 | IGF1R | 0.52266010 |
| 115 | TYK2 | 0.52086405 |
| 116 | PRKDC | 0.51396716 |
| 117 | PINK1 | 0.51286414 |
| 118 | PIK3CA | 0.51257343 |
| 119 | BMPR1B | 0.48309491 |
| 120 | CSNK1E | 0.47824687 |
| 121 | GRK6 | 0.47437077 |
| 122 | KDR | 0.47084043 |
| 123 | TAOK2 | 0.46212476 |
| 124 | MAP3K9 | 0.45928197 |
| 125 | CSNK1D | 0.45802354 |
| 126 | MAPK12 | 0.45207995 |
| 127 | TSSK6 | 0.43859526 |
| 128 | RPS6KA3 | 0.42169862 |
| 129 | MAP2K3 | 0.42102457 |
| 130 | KSR2 | 0.42041258 |
| 131 | MAPK4 | 0.42000802 |
| 132 | TNIK | 0.41892425 |
| 133 | CAMK4 | 0.41018547 |
| 134 | ARAF | 0.40653329 |
| 135 | CSNK1A1 | 0.40538215 |
| 136 | SIK2 | 0.40113945 |
| 137 | PRKACA | 0.40103263 |
| 138 | PDPK1 | 0.39920968 |
| 139 | RPS6KA1 | 0.38134326 |
| 140 | PRKCH | 0.37485110 |
| 141 | PDK2 | 0.37298534 |
| 142 | CAMK2G | 0.36972299 |
| 143 | STK3 | 0.36575172 |
| 144 | AKT2 | 0.36147148 |
| 145 | PRKD1 | 0.34821117 |
| 146 | IRAK1 | 0.34627103 |
| 147 | CDK9 | 0.33988428 |
| 148 | PHKG1 | 0.32972005 |
| 149 | PHKG2 | 0.32972005 |
| 150 | TIE1 | 0.31470030 |
| 151 | MAP3K6 | 0.30524060 |
| 152 | IRAK2 | 0.28984062 |
| 153 | INSR | 0.28124845 |
| 154 | CSNK1G2 | 0.28079922 |
| 155 | CSNK1A1L | 0.27674449 |
| 156 | MYLK | 0.26129743 |
| 157 | CSNK1G3 | 0.26047682 |
| 158 | MAPK7 | 0.25331251 |
| 159 | SGK3 | 0.25094883 |
| 160 | SRC | 0.24377212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.05199348 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.86971979 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03007468 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98020792 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96316472 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.80752512 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69192795 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.65816611 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65750851 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62311778 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52073514 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48457655 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.38040325 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34004193 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.19659008 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11072746 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98546515 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.93906609 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91748171 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87758625 |
| 21 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.80037903 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77744610 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77011045 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76226152 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76055758 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74568706 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73490741 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70935077 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.68412791 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65298972 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64715874 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61593257 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61504154 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.59933691 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58740820 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53936432 |
| 37 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.48692859 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47837692 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47472325 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46977210 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46521387 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43707923 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.42462067 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39074099 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.37424260 |
| 46 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.36240512 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 1.35808298 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.34989782 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31582044 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29766800 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29640251 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29412175 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23374700 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22016870 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18808901 |
| 56 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.17984860 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16491292 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16074327 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13332841 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.10533848 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06848841 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.06318466 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06062992 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01165678 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00516514 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.97659303 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97290357 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95645054 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.92927485 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92129078 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90466777 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90187953 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89020004 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87865790 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83660675 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82686670 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81617796 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.80966808 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.80069704 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79298929 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77509215 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75656812 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.75608762 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.74544337 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74091882 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73584423 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.71896289 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71612937 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68582785 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67344167 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66941477 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66674350 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66373716 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66284949 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65068580 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58987524 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58413034 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58232985 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56002442 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55713923 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55311285 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54947798 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52663799 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50636831 |
| 105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48949674 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.45232719 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.44983526 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43784294 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41801351 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.40090862 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38383525 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35194578 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32766051 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27855522 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25108345 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23186425 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23143224 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20665679 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17020134 |
| 120 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16209653 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14668543 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14156605 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09168444 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05628899 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03729328 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.00758654 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1817336 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.1809250 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | -0.1791989 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1775711 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1715012 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1355367 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1133206 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | -0.1123021 |
| 135 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.0876474 |
| 136 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0796709 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | -0.0731352 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0656770 |
| 139 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0468462 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0213551 |

